Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis

Journal of Neuroscience

Volumn 23, Issue 27, 2003, Pages 9162-9170

  Dou, Huanyu ^a   Birusingh, Kevin ^a   Faraci, Jill ^a   Gorantla, Santhi ^a   Poluektova, Larisa Y ^a   Maggirwar, Sanjay B ^b   Dewhurst, Stephen ^b   Gelbard, Harris A ^b   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

HIV 1 associated dementia; HIV 1 encephalitis; Monocyte derived macrophages; Neuroprotection; Severe combined immunodeficient mice; Sodium valproate

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOPROTEIN GP 120; MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ADJUVANT THERAPY; AIDS RELATED COMPLEX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN CELL; CELL ACTIVATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 ASSOCIATED DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MONOCYTE; MOUSE; NERVE DEGENERATION; NERVE FIBER GROWTH; NERVE FUNCTION; NEURONAL DYSFUNCTION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SCID MOUSE; VIRUS ENCEPHALITIS; VIRUS REPLICATION;

EID: 0141988725     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-27-09162.2003     Document Type: Article

References (59)

1. Adamec E, Yang F, Cole GM, Nixon RA (2001) Multiple-label immunocytochemistry for the evaluation of nature of cell death in experimental models of neurodegeneration. Brain Res Brain Res Protoc 7:193-202.
2. Anderson E, Zink W, Xiong H, Gendelman HE (2002) HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr [Suppl 2] 31:S43-S54.
3. Andreasen N, Vanmechelen E, Vanderstichele H, Davidsson P, Blennow K (2003) Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment. Acta Neurol Scand Suppl 179:47-51.
4. Batrakova EV, Li S, Miller DW, Kabanov AV (1999) Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 16:1366-1372.
5. Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott CW, Lee CM (2000) Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 97:11074-11079.
6. Chen G, Huang LD, Jiang YM, Manji HK (1999) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72:1327-1330.
7. Chen G, Huang LD, Zeng WZ, H KM (2001) Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability. Int J Neuropsychopharmacol 4:47-64.
8. Chenn A, Walsh CA (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365-369.
9. Chung MS, Pepose JS, El-Agha MS, Cavanagh HD, Al-Agha S (2002) Confocal microscopic findings in a case of delayed-onset bilateral diffuse lamellar keratitis after laser in situ keratomileusis. J Cataract Refract Surg 28:1467-1470.
10. Coronas V, Arnault P, Roger M (2002) Cortical diffusible factors increase MAP-2 immunoreactive neuronal population in thalamic cultures. Neurosci Res 43:57-67.
11. Cota M, Mengozzi M, Vicenzi E, Panina-Bordignon P, Sinigaglia F, Transidico P, Sozzani S, Mantovani A, Poli G (2000) Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine. Proc Natl Acad Sci USA 97:9162-9167.
12. Feany MB, Ksiezak-Reding H, Liu WK, Vincent I, Yen SH, Dickson DW (1995) Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol (Berl) 90:37-43.
13. Ferrer I, Barrachina M, Tolnay M, Rey MJ, Vidal N, Carmona M, Blanco R, Puig B (2003) Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease. Brain Pathol 13:62-78.
14. Gendelman HE (2002) Neural immunity: friend or foe? J Neurovirol 8:474-479.
15. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, Skillman D, Meltzer MS (1988) Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167:1428-1441.
16. Gendelman HE, Diesing S, Gelbard H, Swindells S (2003) The neuropathogenesis of HIV-1 infection. In: AIDS and other manifestations of HIV infection, Fourth Edition (Wormser GP, ed), Amsterdam: Elsevier, in press.
17. Genis PJM, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, Epstein LG, Gendelman HE (1992) Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-1718.
18. Gotz J, Nitsch RM (2001) Compartmentalized tau hyperphosphorylation and increased levels of kinases in transgenic mice. NeuroReport 12:2007-2016.
19. Hall AC, Brennan A, Goold RG, Cleverley K, Lucas FR, Gordon-Weeks PR, Salinas PC (2002) Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci 20:257-270.
20. Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, Everson A, Digicaylioglu M, Masliah E (2002) Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection. J Biol Chem 277:32985-32991.
21. Hong DJ, Pei AL, Sun FY, Zhu CQ (2003) Aberrant neuronal expression of mitotic protein, tau and Bax in the rat brain after injection of Abeta(25-35) into the amygdala. Sheng Li Xue Bao 55:142-146.
22. Hori K, Burd PR, Furuke K, Kutza J, Weih KA, Clouse KA (1999) Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. Blood 93:1843-1850.
23. Illig AM, Melia K, Snyder PJ, Badura LL (2000) Sodium valproate alters GnRH-GABA interactions during development in seizure-prone mice. Brain Res 885:192-200.
24. Kabanov AV, Batrakova EV, Alakhov VY (2002) Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82:189-212.
25. Kobayashi K, Nakano H, Hayashi M, Shimazaki M, Fukutani Y, Sasaki K, Sugimori K, Koshino Y (2003) Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J Neurol Sci 208:17-24.
26. Kravcik S, Gallicano K, Roth V, Cassol S, Hawley-Foss N, Badley A, Cameron DW (1999) Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. J Acquir Immune Defic Syndr 21:371-375.
27. Ledergerber BEM, Opravil M, Telenti A, Hirschel B, Battegay M, Vernazza P, Sudre P, Flepp M, Furrer H, Francioli P, Weber R (1999) Clinical progression and virlogical failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 353:863-868.
28. Limoges J, Persidsky Y, Poluektova L, Rasmussen J, Ratanasuwan W, Zelivyanskaya M, McClernon DR, Lanier ER, Gendelman HE (2000) Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice. Neurology 54:379-389.
29. Lipton SA, Gendelman HE (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332:934-940.
30. Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S (1999) HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73:578-586.
31. Manji HK, Moore GJ, Chen G (2000) Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry [Suppl 9] 61:82-96.
32. Marx CE, Jarskog LF, Lauder JM, Lieberman JA, Gilmore JH (2001) Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol Psychiatry 50:743-749.
33. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA (1992a) Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 51:585-593.
34. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA (1992b) Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32:321-329.
35. O'Leary G, Bacon CL, Odumeru O, Fagan C, Fitzpatrick T, Gallagher HC, Moriarty DC, Regan CM (2000) Antiproliferative actions of inhalational anesthetics: comparisons to the valproate teratogen. Int J Dev Neurosci 18:39-45.
36. Perez M, Rojo AI, Wandosell F, Diaz-Nido J, Avila J (2003) Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3. Biochem J 372:129-136.
37. Persidsky Y, Gendelman HE (2002) Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigms. J Neurovirol [Suppl 2] 8:49-52.
38. Persidsky YNH, Sasseville VG, Epstein LG, Gendelman HE (1995) The development of animal model systems for HIV-1 encephalitis and its associated dementia. J Neurovirol 1:229-243.
39. Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet HS, Epstein L, Gelbard H, Flanagan E, Reinhard J, Pirruccello SJ, Gendelman HE (1996) Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol 149:1027-1053.
40. Saatman KE, Graham DI, McIntosh TK (1998) The neuronal cytoskeleton is at risk after mild and moderate brain injury. J Neurotrauma 15:1047-1058.
41. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998. Neurology 56:257-260.
42. San Jose I, Vazquez E, Garcia-Atares N, Huerta JJ, Vega JA, Represa J (1997) Differential expression of microtubule associated protein MAP-2 in developing cochleovestibular neurons and its modulation by neurotrophin-3. Int J Dev Biol 41:509-519.
43. Sanders VJ, Mehta AP, White MG, Achim CL (1998) A murine model of HIV encephalitis: xenotransplantation of HIV-infected human neuroglia into SCID mouse brain. Neuropathol Appl Neurobiol 24:461-467.
44. Schielke E (1993) HIV encephalopathy: clinical aspects, neuropathology and pathogenesis. Nervenarzt 64:83-90.
45. Schifitto G, Kieburtz K, McDermott MP, McArthur J, Marder K, Sacktor N, Palumbo D, Selnes O, Stern Y, Epstein L, Albert S (2001) Clinical trials in HIV-associated cognitive impairment: cognitive and functional outcomes. Neurology 56:415-418.
46. Stern Y, McDermott MP, Albert S, Palumbo D, Selnes OA, McArthur J, Sacktor N, Schifitto G, Kieburtz K, Epstein L, Marder KS (2001) Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol 58:473-479.
47. Stoica BA, Movsesyan VA, Lea IV PM, Faden AI (2003) Ceramide-induced neuronal apoptosis is associated with dephosphorylation of Akt, BAD, FKHR, GSK-3beta, and induction of the mitochondrial-dependent intrinsic caspase pathway. Mol Cell Neurosci 22:365-382.
48. Swindells S, Zheng J, Gendelman HE (1999) HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions. AIDS Patient Care STDS 13:153-163.
49. Tariot PN, Loy R, Ryan JM, Porsteinsson A, Ismail S (2002) Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales. Adv Drug Deliv Rev 54:1567-1577.
50. Tong N, Sanchez JF, Maggirwar SB, Ramirez SH, Guo H, Dewhurst S, Gelbard HA (2001) Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 13:1913-1922.
51. Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, Sadiq S, Morgello S, Sharer L, Volsky DJ (2003) Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 13:144-154.
52. Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA (1989) Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3:154-171.
53. Wang Y, Zhou D, Wang B, Li H, Chai H, Zhou Q, Zhang S, Stefan H (2003) A kindling model of pharmacoresistant temporal lobe epilepsy in Sprague-Dawley rats induced by Coriaria lactone and its possible mechanism. Epilepsia 44:475-488.
54. Weiss JM, Nath A, Major EO, Berman JW (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 163:2953-2959.
55. Wiley CA, Schrier RD, Morey M, Achim C, Venable JC, Nelson JA (1991a) Pathogenesis of HIV encephalitis. Acta Pathol Jpn 41:192-196.
56. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991b) Neocortical damage during HIV infection. Ann Neurol 29:651-657.
57. Yeh MW, Kaul M, Zheng J, Nottet HS, Thylin M, Gendelman HE, Lipton SA (2000) Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of L-cysteine. J Immunol 164:4265-4270.
58. Zechner D, Fujita Y, Hulsken J, Muller T, Walther I, Taketo MM, Crenshaw III EB, Birchmeier W, Birchmeier C (2003) Beta-catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol 258:406-418.
59. Zheng J, Thylin MR, Cotter RL, Lopez AL, Ghorpade A, Persidsky Y, Xiong H, Leisman GB, Che M, Gendelman HE (2001) HIV-1 infected and immune competent mononuclear phagocytes induce quantitative alterations in neuronal dendritic arbor: relevance for HIV-1-associated dementia. Neuro Res 3:443-459.